Back
Pertussis
General information
-
- Surveillance since 2017
- State : active
- Yearly surveillance : Data are published on a yearly time scale and updated when our yearly report is published
-
Case definition :
Laboratory-confirmed case: patient suspected of having pertussis, confirmed with a positive PCR analysis or a positive culture Epidemiologically-confirmed case: patient suspected of having pertussis who had contact in the three weeks prior to the beginning of his/her cough with a laboratory-confirmed case (by PCR or culture)(the potential contaminant of this epidemiologically-confirmed case), or who had contact in the communicable period of the disease with someone who presented signs of pertussis and had a laboratory confirmation with PCR or culture (secondary case of this epidemiologically-confirmed case). - Description for each case: age; sex; presence of fever; presence of cough, and, if present, characteristics of the cough and time between the beginning of the cough and the consultation; other clinical signs, if no cough; hospitalization requested by GP; immunization status (if vaccinated: type of vaccine, date of last vaccination, number of dose(s), method of information collection); microbiological examination (PCR or culture) and, if performed, the results and the time between the beginning of the cough and the sampling; history of coughing cases in entourage (epidemiological link, relationship, biological confirmation, age and sex, if previously declared).
Lastest data
Data of this page are updated each year when our yearly report is published
Find more data and visualization on pages Data access
Incidence rate of {{name}} in France (mainland) from start of surveillance
All publications associated with this disease
. Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020. Euro Surveill. 2022. 27(17) PubMed HAL
PMC doi:10.2807/1560-7917.ES.2022.27.17.2100515
. Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018. Euro Surveill. 2021. 26(4) PubMed HAL
PMC doi:10.2807/1560-7917.ES.2021.26.4.1900762
. Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Euro Surveill. 2011. 16(5) PubMed
Euro Surv
. Pertussis prevention and diagnosis practices for adolescents and adults among a national sample of French general practitioners. Prev Med. 2010. 51(1):90-1 PubMed doi:10.1016/j.ypmed.2010.04.001
. [Awareness and adherence to Pertussis vaccination guidelines by occupational medicine physicians in Paris healthcare institution]. Med Mal Infect. 2009. 39(5):325-9 PubMed doi:10.1016/j.medmal.2009.01.006
. Is pertussis being considered as a cause of persistent cough among adults? Eur J Epidemiol. 2003. 18(10):1013-5 PubMed doi:10.1023/a:1025860917328
Other pages in this website
Websites recommanded regarding this disease
- Centre National de Référence de la coqueluche et autres bordetelloses (Institut Pasteur)
- Dossier d'informations générales sur la coqueluche (Ministčre des Solidarités et de la Santé)
- Dossier d'informations générales sur la coqueluche (Santé publique France)
- Dossiers d'informations générales sur la coqueluche (CDC - USA)
- Dossiers d'informations générales sur la coqueluche (ECDC - Europe)